Christopher Stone

2009

In 2009, Christopher Stone earned a total compensation of $590.7K as Vice President, General Counsel and Secretary at PDL BioPharma.

Compensation breakdown

Non-Equity Incentive Plan$131,750
Salary$284,167
Stock Awards$165,000
Other$9,800
Total$590,717

Stone received $284.2K in salary, accounting for 48% of the total pay in 2009.

Stone also received $131.8K in non-equity incentive plan, $165K in stock awards and $9.8K in other compensation.

Rankings

In 2009, Christopher Stone's compensation ranked 6,286th out of 9,885 executives tracked by ExecPay. In other words, Stone earned more than 36.4% of executives.

ClassificationRankingPercentile
All
6,286
out of 9,885
36th
Division
Manufacturing
2,291
out of 3,690
38th
Major group
Chemicals And Allied Products
495
out of 866
43rd
Industry group
Drugs
333
out of 638
48th
Industry
Biological Products, Except Diagnostic Substances
66
out of 133
50th
Source: SEC filing on April 23, 2012.

Stone's colleagues

We found three more compensation records of executives who worked with Christopher Stone at PDL BioPharma in 2009.

2009

John McLaughlin

PDL BioPharma

Chief Executive Officer

2009

Christine Larson

PDL BioPharma

Chief Financial Officer

2009

Karen Wilson

PDL BioPharma

Former Vice President of Finance and Principal Accounting Officer

News

You may also like